A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
A vaccine to fight dementia? It turns out there may already be one – shots that prevent painful shingles also appear to ...
Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...
British drugs giant GSK is launching a ground-breaking investigation that could save millions of Britons from developing ...
As its candidate advances through clinical trials, Curevo is setting up future rivalry with GSK’s Shingrix (zoster vaccine recombinant) – the only US Food and Drug Administration (FDA ...
As its candidate advances through clinical trials, Curevo is setting up future rivalry with GSK’s Shingrix (zoster vaccine recombinant) – the only US Food and Drug Administration (FDA)-approved ...
In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former GSK leaders to its board. The biotech’s series B was led by new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback